Sponsored by

NovoCure Trial

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 601 to 625 of about 5880

Previous 25

Website Changes

11/11/2021

Temporary opening of the blood-brain barrier with the nitrone compound OKN-007

11/11/2021

Chimerix Announces Upcoming Presentations at the Society for Neuro-Oncology Annual Meeting 2021

11/05/2021

Japan offers new treatment option for brain cancer

11/05/2021

Jaime Leandro Foundation treats first cancer patient

11/04/2021

Chimerix Announces Positive Topline Results for ONC201 in Recurrent H3 K27M-mutant Glioma

11/04/2021

A new treatment for brain tumors available in France (Onc-201)

11/01/2021

External Controls to Improve on Glioblastoma Clinical Trials

10/29/2021

Exploring the efficacy of tumor electric field therapy against glioblastoma: An in vivo and in vitro study

10/28/2021

xCures launched xUTILITY Real-World Oncology Datasets

10/27/2021

A combined treatment regimen of MGMT-modified ?d T cells and temozolomide chemotherapy is effective against primary high grade gliomas

10/26/2021

Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial

10/20/2021

NY hospital recruiting cancer patients for groundbreaking treatment loopcayman 20 hrs ago

10/20/2021

PLUS THERAPEUTICS ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR 186RNL FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES

10/16/2021

Systemic coagulation is activated in patients with meningioma and glioblastoma

10/07/2021

ONC206 for Treatment of Newly Diagnosed, or Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant Brain Tumors (PNOC 023)

10/04/2021

Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I/II clinical trial

10/04/2021

Sharing your GBM Experience Helps Others

09/30/2021

Oblato Announces that it has received a Positive Response from the FDA for the use of OKN-007 for patients with high-grade gliomas in an Expanded Access Program

09/28/2021

Neuroscientist Michelle Monje awarded MacArthur `genius grant`

09/26/2021

Musella Foundation awards $50,000 brain tumor research grant!

09/25/2021

xINFORM - Personalized Treatment Options Software

09/25/2021

Sunday`s 9/26/21 webinar is postponed!

09/23/2021

Novel Virus Targeting Deadly Brain Tumors Shows Early Promise

09/21/2021

The Musella Foundation presents two webinars this week!

09/12/2021

Study protocol for OptimalTTF-2: enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: a phase 2, multi-center, randomized, prospective, interventional trial

Our privacy / cookie policy has changed.
Click HERE to read it!